Member Info for Sangijuelas1

Yeah I notice that rather than counter the points made you prefer to play the man and not the ball

So what do you think 2024 revenue will be?

It's fine to say it is expected to treble but when there's such a low base to start from

You are clearly looking at the wrong Logica.

They don't have a website or anything. Look so so credible.

And when you Google them all you get is Twitter posts on the Angle price target.

Never heard of an individual analyst before. Must mean some twat off Twitter.

Strange to describe it as an analyst consensus

Revenue from the Japanese deal is £250k.

Not enough to keep the lights on

And Angle have attended on previous occasions along with multiple other conferences.

So what? There have been no institutional buys since last week's news.

Just pumper dumpers and retail investors.

The stock is not covered by any credible analysts other than the house broker Berenberg.

Graphcore is sadly a write off for Molten. They have said they need a 1bn in funding for the next 3-4 years.

If they were to get that the Molten would be diluted so much as to make their current holding worthless. The alternative would be a buyout of the tech at a rock bottom price as the alternative would be liquidation.

Yeah I am actually going to take a pass on this now that I have seen Newlands latest performance.

Wish you all luck. You will need it

They are Angle's broker. You would hardly expect them to be negative.

Need to see something independent from another broker before taking it seriously

So how much additional revenue do you think will be generated in 2024 from this particular rabbit?

That is based on them running on a shoestring having closed the US site.

The new development may require some additional funding

As I said I am now less likely to buy back having seen Newland spouting BS about Elisa being a HUUUGE pharma company when it's barely mid size

The 80p raise was in July 22 so that's 18 months ago.

They last reported having £15m and they need £10m a year for staff costs

Whenever you hear the following avoid like the plague

-MMs coming for your shares

-US buyers

-and my favourite NT to buy

In April last year it rose on similar type news of a couple of pharma services contracts. Was pumped to 30p or so then dropped back shortly after to all time lows.

Some of us have been here before

Seriously it will be a slow bleed back down to about 18.

I see value init about 20p but only for the Sipp.

Despite the news nothing has really changed.

The pumpers are dumping it. Nothing to do with MMs.

And you clearly haven't seen an Angle presentation before.

Who can forget the one where Newland said he wasn't interested in shareholders that weren't prepared to wait another 10 years, when they had already been invested for over 10